KKO INTERNATIONAL SA (ALKKO.PA)

FR0013374667 - Common Stock

0.185  -0.01 (-3.9%)

Fundamental Rating

1

We assign a fundamental rating of 1 out of 10 to ALKKO. ALKKO was compared to 57 industry peers in the Food Products industry. ALKKO has a bad profitability rating. Also its financial health evaluation is rather negative. ALKKO is valied quite expensively at the moment, while it does show a decent growth rate.



2

1. Profitability

1.1 Basic Checks

ALKKO had negative earnings in the past year.
In the past year ALKKO had a positive cash flow from operations.
ALKKO had negative earnings in each of the past 5 years.
ALKKO had a negative operating cash flow in each of the past 5 years.

1.2 Ratios

Looking at the Return On Assets, with a value of -3.04%, ALKKO is doing worse than 79.63% of the companies in the same industry.
Looking at the Return On Equity, with a value of -9.35%, ALKKO is doing worse than 81.48% of the companies in the same industry.
Looking at the Return On Invested Capital, with a value of 6.41%, ALKKO is in the better half of the industry, outperforming 64.81% of the companies in the same industry.
Industry RankSector Rank
ROA -3.04%
ROE -9.35%
ROIC 6.41%
ROA(3y)-5.88%
ROA(5y)-8.95%
ROE(3y)-19.07%
ROE(5y)-21.28%
ROIC(3y)N/A
ROIC(5y)N/A

1.3 Margins

The Operating Margin of ALKKO (26.80%) is better than 100.00% of its industry peers.
With an excellent Gross Margin value of 69.88%, ALKKO belongs to the best of the industry, outperforming 100.00% of the companies in the same industry.
Industry RankSector Rank
OM 26.8%
PM (TTM) N/A
GM 69.88%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A

0

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so ALKKO is destroying value.
ALKKO has more shares outstanding than it did 1 year ago.
The number of shares outstanding for ALKKO has been increased compared to 5 years ago.
ALKKO has a worse debt/assets ratio than last year.

2.2 Solvency

Based on the Altman-Z score of 0.99, we must say that ALKKO is in the distress zone and has some risk of bankruptcy.
With a Altman-Z score value of 0.99, ALKKO is not doing good in the industry: 81.48% of the companies in the same industry are doing better.
A Debt/Equity ratio of 1.13 is on the high side and indicates that ALKKO has dependencies on debt financing.
ALKKO's Debt to Equity ratio of 1.13 is on the low side compared to the rest of the industry. ALKKO is outperformed by 81.48% of its industry peers.
Industry RankSector Rank
Debt/Equity 1.13
Debt/FCF N/A
Altman-Z 0.99
ROIC/WACC0.84
WACC7.6%

2.3 Liquidity

A Current Ratio of 1.14 indicates that ALKKO should not have too much problems paying its short term obligations.
Looking at the Current ratio, with a value of 1.14, ALKKO is doing worse than 66.67% of the companies in the same industry.
ALKKO has a Quick Ratio of 1.14. This is a bad value and indicates that ALKKO is not financially healthy enough and could expect problems in meeting its short term obligations.
The Quick ratio of ALKKO (0.39) is worse than 88.89% of its industry peers.
Industry RankSector Rank
Current Ratio 1.14
Quick Ratio 0.39

4

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 71.30% over the past year.
ALKKO shows a strong growth in Revenue. In the last year, the Revenue has grown by 452.63%.
Measured over the past years, ALKKO shows a very strong growth in Revenue. The Revenue has been growing by 47.80% on average per year.
EPS 1Y (TTM)71.3%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%200%
Revenue 1Y (TTM)452.63%
Revenue growth 3Y84.49%
Revenue growth 5Y47.8%
Sales Q2Q%710.81%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

0

4. Valuation

4.1 Price/Earnings Ratio

Industry RankSector Rank
PE N/A
Fwd PE N/A

4.2 Price Multiples

77.78% of the companies in the same industry are cheaper than ALKKO, based on the Enterprise Value to EBITDA ratio.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 19.41

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

No dividends for ALKKO!.
Industry RankSector Rank
Dividend Yield N/A

KKO INTERNATIONAL SA

EPA:ALKKO (1/6/2025, 7:00:00 PM)

0.185

-0.01 (-3.9%)

Chartmill FA Rating
GICS SectorConsumer Staples
GICS IndustryGroupFood, Beverage & Tobacco
GICS IndustryFood Products
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst OwnersN/A
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap25.68M
AnalystsN/A
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 4.65
P/FCF N/A
P/OCF 46.69
P/B 3.74
P/tB 3.74
EV/EBITDA 19.41
EPS(TTM)0
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-0.01
FCFYN/A
OCF(TTM)0
OCFY2.14%
SpS0.04
BVpS0.05
TBVpS0.05
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -3.04%
ROE -9.35%
ROCE 8.81%
ROIC 6.41%
ROICexc 6.74%
ROICexgc 6.74%
OM 26.8%
PM (TTM) N/A
GM 69.88%
FCFM N/A
ROA(3y)-5.88%
ROA(5y)-8.95%
ROE(3y)-19.07%
ROE(5y)-21.28%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score6
Asset Turnover0.26
Health
Industry RankSector Rank
Debt/Equity 1.13
Debt/FCF N/A
Debt/EBITDA 4.38
Cap/Depr 483.78%
Cap/Sales 25.43%
Interest Coverage 2.42
Cash Conversion 31.05%
Profit Quality N/A
Current Ratio 1.14
Quick Ratio 0.39
Altman-Z 0.99
F-Score6
WACC7.6%
ROIC/WACC0.84
Cap/Depr(3y)245.17%
Cap/Depr(5y)260.29%
Cap/Sales(3y)157.64%
Cap/Sales(5y)200.77%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)71.3%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%200%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)452.63%
Revenue growth 3Y84.49%
Revenue growth 5Y47.8%
Sales Q2Q%710.81%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y165.53%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y71.29%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y122.92%
OCF growth 3YN/A
OCF growth 5YN/A